Characterization of amyloidogenic immunoglobulin light chains directly from serum by on-line immunoaffinity isolation

Biomedical Chromatography

Volumn 18, Issue 3, 2004, Pages 191-201

  Bergen III, H Robert ^a   Abraham, Roshini S ^a   Johnson, Kenneth L ^a   Bradwell, Arthur R ^b   Naylor, Stephen ^a,c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c Beyond Genomics   (United States)

Author keywords

Desalting trap; ESI MS; Immunoaffinity cartridge

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BODY FLUIDS; DESALINATION; ELECTROSPRAY IONIZATION; GLYCOPROTEINS; MASS SPECTROMETRY; SPECTRUM ANALYSIS;

B LYMPHOCYTES; DESALTING TRAP; ESI MS; IMMUNO-AFFINITY ISOLATION; IMMUNOAFFINITY; IMMUNOAFFINITY CARTRIDGE; IMMUNOGLOBULIN LIGHT CHAINS; LIGHT CHAIN; PLASMA CELLS; SYSTEMIC AMYLOIDOSIS;

PROTEINS;

AMYLOID; BENCE JONES PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

AMYLOIDOSIS; ANTIBODY AFFINITY; ARTICLE; AUTOMATION; CONTROLLED STUDY; COVALENT BOND; DIAGNOSTIC VALUE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; ISOLATION PROCEDURE; METHODOLOGY; MONOCLONAL IMMUNOGLOBULINEMIA; ONLINE SYSTEM; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN PURIFICATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE;

JONES;

EID: 2342653503     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.323     Document Type: Article

References (29)

1. Abraham RS, Clark RJ, Bryant SC. Lymp JF, Larson T, Kyle RA and Katzmann JA. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. Clinical Chemistry 2002: 48: 655-657.
2. Bergen HR, Lacey JM, O'Brien JF and Naylor S. Online single-step analysis of blood proteins: the transferrin story. Analytical Biochemistry 2001a. 296: 122-129.
3. Bergen HR, Murray MJ, and Naylor S. Rapid analysis of eicosanoids from complex matrices. 49th Annual ASMS Conference on Mass Spectrometry and Allied Topics, Chicago, IL, 2001b.
4. Berggard I and Peterson PA. Polymeric forms of free normal kappa and lambda chains of human immunoglobulin. Journal of Biolical Chemistry 1969; 244: 4299-4307.
5. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT and Drew R. Highly sensitive automated immunoassay for immunoglobulin free light chains in serum and urine. Clinical Chemistry 2001; 47: 673-680.
6. Drayson MT, Tang LX, Drew R, Mead GP, Carr-Smith HD and Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001: 97: 2900-2902.
7. Dwulet FE. O'Connor TP and Benson MD. Polymorphism in a kappa 1 primary (AL) amyloid protein (BAN). Molecular Immunology 1986: 23: 73-78.
8. Elghetany MT, Saleem A and Barr K. The Congo red stain revisited. Annals of Clinical and Laboratory Science 1995; 19: 190-195.
9. Feiner HD. Pathology of dysproteinemia: light chain amyloidosis, non-amyloid immunoglobulin deposition disease, cryoglobulinemia syndromes, and macroglobulinemia of Waldenstrom. Human Pathology 1988: 19: 1255-1272.
10. Gertz MA, Greipp PR and Kyle RA. Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow. Journal of Laboratory and Clinical Medicine 1991; 118: 33-39.
11. Gertz M, Lacy M and Dispenzieri A. Amyloidosis. Hematology/Oncology Clinics of North America 1999; 13: 1211-1233.
12. Gillmore JD, Hawkins PN and Pepys MB. Amyloidosis: A review of recent diagnostic and therapeutic developments. British Journal of Haematology 1997; 99: 245-256.
13. Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses (published in two parts). New England Journal of Medicine 1980; 302: 1283-1292, 1333-1343.
14. Grey HM and Kohler PF. A case of tetramer Bence Jones proteinaemia. Clinical Experimental Immunology 1968; 3: 277-285.
15. Hurle MR, Helms LR, Li L, Chan W and Wetzel R. A role for destabilizing amino acid replacements in light-chain amyloidosis. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 5446-5450.
16. Isobe T and Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. New England Journal of Medicine 1974; 290: 473-477.
17. Kosaka M, Iishi Y, Okagawa K, Saito S, Sugihara J and Muto Y. Tetramer Bence Jones protein in the immunoproliferative diseases. Angioimmunoblastic lymphadenopathy, primary amyloidosis, and multiple myeloma. America Journal of Clinical Pathology 1989; 91: 639-646.
18. Kyle RA and Gerta MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Seminars in Hematology 1995; 32: 45-59.
19. Kyle RA, Greipp PR and O'Fallon WM. Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood 1986; 68: 220-224.
20. Lacey JM, Bergen HR, Magera, MJ, Naylor S and O'Brien JF. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clinical Chemistry 2001; 47: 513-518.
21. Loo JA. Observation of large subunit protein complexes by electrospray-ionization-mass spectrometry. Journal of Mass Spectrometry 1995; 30: 180-183.
22. Pascali E. Diagnosis and treatment of primary anyloidosis. Critical Reviews in Oncology-Hematology 1995; 19: 149-181.
23. Raffen R, Dieckman LJ, Szpunar M, Wunschl C, Pokkuluri PR, Dave P, Wilkins-Stevens P, Cai X, Schiffer M. and Stevens FJ. Physico-chemical consequences of amino acid variations that contribue to fibril formation by immunoglobulin light chains. Protein Science 1999; 8: 509-517.
24. Solomon A, Weiss DT and Pepys MB. Induction in mice of human light-chain-associated amyloidosis. American Journal of Pathology 1992; 140: 629-637.
25. Stevens FJ, Chang CH and Schiffer M. Self-association of human immunoglobulin kappa 1 light chains: role of the third hypervariable region. Proceedings of the National Academy of Sciences of the USA 1980; 77: 1144-1148.
26. Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. Blood 1990, 75: 531-545.
27. Wetzel R. Domain stability in immunoglobulin light chain deposition disorders. Advanced Protein Chemistry 1997; 50: 183-242.
28. Wu SS, Brady K, Anderson JJ, Vezena R, Skinner M, Neiman RS and Wolf BC. The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis. American Journal of Clinical Pathology 1991; 96: 95-99.
29. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D and Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nature and Medicine 2000: 6: 643-651.